Skip to main content
Log in

Perihepatic Lymph Node Micrometastases Impact Outcome after Partial Hepatectomy for Colorectal Metastases

  • Hepatic and Pancreatic Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Hepatectomy for resectable colorectal liver metastases provides a survival advantage but is usually reserved for patients without extrahepatic disease. Metastases to perihepatic lymph nodes (LN) occur with controversial significance. This study uses standard pathologic analysis and immunohistochemistry (IHC) to determine the impact of occult metastatic disease to perihepatic LN in patients with colorectal cancer undergoing hepatectomy.

Methods

Fifty-nine patients with liver metastases from colon or rectal primary cancer were studied prospectively. Perihepatic LN were sampled from the portocaval, pancreaticoduodenal, and common hepatic artery regions. All LN were analyzed using hematoxylin and eosin (H&E), and those negative by H&E were analyzed using IHC for cytokeratin. Recurrence and survival were compared amongst LN groups.

Results

Median follow-up was 42 months for survivors. There were eight patients with metastatic disease to at least one perihepatic LN identified by H&E and fourteen patients with metastases identified by IHC only. Forty-one patients (70%) recurred after resection, and patients with LN metastases, regardless of detection method, had a shorter recurrence-free survival compared to node negative patients. However, patterns of recurrence differed by LN group. Compared to H&E-positive patients, IHC-positive patients had a better overall survival and were more likely to recur at a single site amenable to salvage resection.

Conclusions

In patients with hepatic colorectal metastases, IHC analysis of perihepatic LN adds prognostic value regarding the timing and burden of recurrence after resection. Routine IHC assessment of perihepatic LN is reasonable since the information garnered would potentially influence postresection chemotherapy recommendations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

FIG. 1.
FIG 2.

Similar content being viewed by others

REFERENCES

  1. Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997;15:938–46

    PubMed  CAS  Google Scholar 

  2. Weber SM, Jarnagin WR, DeMatteo RP, et al. Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol 2000;7:643–50

    Article  PubMed  CAS  Google Scholar 

  3. Imamura H, Seyama Y, Kokudo N, et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 2003; 138:1198–206; discussion 1206

    Article  PubMed  Google Scholar 

  4. Elias D, Ouellet JF, Bellon N, et al. Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 2003; 90:567–74

    Article  PubMed  CAS  Google Scholar 

  5. Elias D, Sideris L, Pocard M, et al. Results of R0 resection for colorectal liver metastases associated with extrahepatic disease. Ann Surg Oncol 2004; 11:274–80

    Article  PubMed  Google Scholar 

  6. Beckurts KT, Holscher AH, Thorban S, et al. Significance of lymph node involvement at the hepatic hilum in the resection of colorectal liver metastases. Br J Surg 1997; 84:1081–4

    Article  PubMed  CAS  Google Scholar 

  7. Elias D, Saric J, Jaeck D, et al. Prospective study of microscopic lymph node involvement of the hepatic pedicle during curative hepatectomy for colorectal metastases. Br J Surg 1996; 83:942–5

    Article  PubMed  CAS  Google Scholar 

  8. Ercolani G, Grazi GL, Ravaioli M, et al. The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy. Ann Surg 2004; 239:202–9

    Article  PubMed  Google Scholar 

  9. Jaeck D, Nakano H, Bachellier P, et al. Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study. Ann Surg Oncol 2002; 9:430–8

    Article  PubMed  Google Scholar 

  10. Laurent C, Sa Cunha A, Rullier E, et al. Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis. J Am Coll Surg 2004; 198:884–91

    Article  PubMed  Google Scholar 

  11. Fuhrman GM, Curley SA, Hohn DC, et al. Improved survival after resection of colorectal liver metastases. Ann Surg Oncol 1995; 2:537–41

    Article  PubMed  CAS  Google Scholar 

  12. Kokudo N, Sato T, Seki M, et al. Hepatic lymph node involvement in resected cases of liver metastases from colorectal cancer. Dis Colon Rectum 1999; 42:1285–90; discussion 1290–1

    Article  PubMed  CAS  Google Scholar 

  13. Rodgers MS, McCall JL. Surgery for colorectal liver metastases with hepatic lymph node involvement: a systematic review. Br J Surg 2000; 87:1142–55

    Article  PubMed  CAS  Google Scholar 

  14. Nakamura S, Suzuki S, Konno H. Resection of hepatic metastases of colorectal carcinoma: 20 years’ experience. J Hepatobiliary Pancreat Surg 1999; 6:16–22

    Article  PubMed  CAS  Google Scholar 

  15. Nakamura S, Yokoi Y, Suzuki S, et al. Results of extensive surgery for liver metastases in colorectal carcinoma. Br J Surg 1992; 79:35–8

    Article  PubMed  CAS  Google Scholar 

  16. Karimipour DJ, Lowe L, Su L, et al. Standard immunostains for melanoma in sentinel lymph node specimens: which ones are most useful? J Am Acad Dermatol 2004; 50:759–64

    Article  PubMed  Google Scholar 

  17. Mullenix PS, Brown TA, Meyers MO, et al. The association of cytokeratin-only-positive sentinel lymph nodes and subsequent metastases in breast cancer. Am J Surg 2005; 189:606–9; discussion 609

    Article  PubMed  CAS  Google Scholar 

  18. Bilchik AJ, Nora D, Tollenaar RA, et al. Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis. Eur J Cancer 2002; 38:977–85

    Article  PubMed  CAS  Google Scholar 

  19. Feig BW, Curley S, Lucci A, et al. A caution regarding lymphatic mapping in patients with colon cancer. Am J Surg 2001; 182:707–12

    Article  PubMed  CAS  Google Scholar 

  20. Tschmelitsch J, Klimstra DS, Cohen AM. Lymph node micrometastases do not predict relapse in stage II colon cancer. Ann Surg Oncol 2000; 7:601–8

    PubMed  CAS  Google Scholar 

  21. Turner RR, Nora DT, Trocha SD, et al. Colorectal carcinoma nodal staging. Frequency and nature of cytokeratin-positive cells in sentinel and nonsentinel lymph nodes. Arch Pathol Lab Med 2003; 127:673–9

    PubMed  Google Scholar 

  22. Grobmyer SR, Wang L, Gonen M, et al. Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Ann Surg 2006; 244:260–4

    Article  PubMed  Google Scholar 

  23. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230:309–18; discussion 318–21

    Article  PubMed  CAS  Google Scholar 

  24. Elias DM, Ouellet JF. Incidence, distribution, and significance of hilar lymph node metastases in hepatic colorectal metastases. Surg Oncol Clin North Am 2003; 12:221–9

    Article  Google Scholar 

  25. Jaeck D. The significance of hepatic pedicle lymph nodes metastases in surgical management of colorectal liver metastases and of other liver malignancies. Ann Surg Oncol 2003; 10:1007–11

    Article  PubMed  Google Scholar 

  26. Calhoun KE, Hansen NM, Turner RR, et al. Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection. Am J Surg 2005; 190:588–91

    Article  PubMed  Google Scholar 

  27. Pendas S, Dauway E, Cox CE, et al. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Am Surg 1999; 65:500–5; discussion 505–6

    PubMed  CAS  Google Scholar 

  28. Ross GL, Shoaib T, Scott J, et al. The impact of immunohistochemistry on sentinel node biopsy for primary cutaneous malignant melanoma. Br J Plast Surg 2003; 56:153–5

    Article  PubMed  CAS  Google Scholar 

  29. Spanknebel K, Coit DG, Bieligk SC, et al. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis. Am J Surg Pathol 2005; 29:305–17

    Article  PubMed  Google Scholar 

  30. Schlag PM, Bembenek A, Schulze T. Sentinel node biopsy in gastrointestinal-tract cancer. Eur J Cancer 2004; 40:2022–32

    Article  PubMed  CAS  Google Scholar 

  31. Kane JM 3rd, Kahlenberg MS, Rodriguez-Bigas MA, et al. Intraoperative hepatic lymphatic mapping in patients with liver metastases from colorectal carcinoma. Am Surg 2002; 68:745–50

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to William R. Jarnagin MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bennett, J.J., Schmidt, C.R., Klimstra, D.S. et al. Perihepatic Lymph Node Micrometastases Impact Outcome after Partial Hepatectomy for Colorectal Metastases. Ann Surg Oncol 15, 1130–1136 (2008). https://doi.org/10.1245/s10434-007-9802-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-007-9802-0

Keywords

Navigation